Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

NEW
FRA:LGDN (USA)   Ordinary Shares - Class B
€ 250 -2 (-0.79%) Aug 10
31.13
P/B:
6.57
Market Cap:
€ 5.10B ($ 5.88B)
Enterprise V:
€ 4.89B ($ 5.64B)
Volume:
0
Avg Vol (2M):
20.00
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

Apple Inc Stock Intrinsic Values -